NCT02599363View on ClinicalTrials.gov

A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 12, 2019

Study Completion Date

March 12, 2019

Conditions
Advanced Breast Cancer
Interventions
DRUG

Ribociclib (LEE011)

DRUG

Paclitaxel

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02599363 - A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer | Biotech Hunter | Biotech Hunter